questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Effets physiologiques des médicaments
Agents neuromédiateurs
Agents cholinergiques
Inhibiteurs de la libération d'acétylcholine
Inhibiteurs de la libération d'acétylcholine : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Diagnostic
Acétylcholine
Neurologie
Tests électromyographiques
Acétylcholine
Analyse sanguine
Faiblesse musculaire
Fatigue
Acétylcholine
Antécédents médicaux
Acétylcholine
Évaluation clinique
Imagerie cérébrale
Pathologies neurologiques
Acétylcholine
Symptômes
5
Faiblesse musculaire
Fatigue
Coordination
Troubles de la mémoire
Concentration
Acétylcholine
Difficultés respiratoires
Acétylcholine
Système respiratoire
Âge
Symptômes
Acétylcholine
Nausées
Troubles gastro-intestinaux
Acétylcholine
Prévention
5
Prévention
Mode de vie sain
Acétylcholine
Alimentation équilibrée
Antioxydants
Acétylcholine
Exercice physique
Fonction musculaire
Acétylcholine
Stress
Symptômes
Acétylcholine
Contrôles réguliers
Surveillance
Acétylcholine
Traitements
5
Médicaments anticholinestérasiques
Thérapies physiques
Acétylcholine
Efficacité des traitements
Qualité de vie
Acétylcholine
Effets secondaires
Nausées
Acétylcholine
Rééducation physique
Renforcement musculaire
Acétylcholine
Traitements personnalisés
Acétylcholine
Médecine personnalisée
Complications
5
Complications
Troubles respiratoires
Crises musculaires
Hospitalisations
Surveillance
Acétylcholine
Risque de décès
Inhibition sévère
Acétylcholine
Complications réversibles
Traitement approprié
Acétylcholine
Gestion des complications
Approche multidisciplinaire
Acétylcholine
Facteurs de risque
5
Facteurs de risque
Maladies auto-immunes
Antécédents familiaux
Âge avancé
Facteurs de risque
Acétylcholine
Médicaments
Risque
Acétylcholine
Mode de vie sédentaire
Mauvaise alimentation
Acétylcholine
Infections virales
Risque
Acétylcholine
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs de la libération d'acétylcholine : Questions médicales les plus fréquentes",
"headline": "Inhibiteurs de la libération d'acétylcholine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Inhibiteurs de la libération d'acétylcholine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-06",
"dateModified": "2025-05-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Inhibiteurs de la libération d'acétylcholine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Agents cholinergiques",
"url": "https://questionsmedicales.fr/mesh/D018678",
"about": {
"@type": "MedicalCondition",
"name": "Agents cholinergiques",
"code": {
"@type": "MedicalCode",
"code": "D018678",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.120"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs de la libération d'acétylcholine",
"alternateName": "Acetylcholine Release Inhibitors",
"code": {
"@type": "MedicalCode",
"code": "D065087",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ikunobu Muramatsu",
"url": "https://questionsmedicales.fr/author/Ikunobu%20Muramatsu",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan."
}
},
{
"@type": "Person",
"name": "Junsuke Uwada",
"url": "https://questionsmedicales.fr/author/Junsuke%20Uwada",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan."
}
},
{
"@type": "Person",
"name": "Kiyonao Sada",
"url": "https://questionsmedicales.fr/author/Kiyonao%20Sada",
"affiliation": {
"@type": "Organization",
"name": "Division of Genomic Science and Microbiology, School of Medicine, University of Fukui, Eiheiji, Fukui, Japan."
}
},
{
"@type": "Person",
"name": "Takayoshi Masuoka",
"url": "https://questionsmedicales.fr/author/Takayoshi%20Masuoka",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan."
}
},
{
"@type": "Person",
"name": "Takashi Yazawa",
"url": "https://questionsmedicales.fr/author/Takashi%20Yazawa",
"affiliation": {
"@type": "Organization",
"name": "Division of Cellular Signal Transduction, Department of Biochemistry, Asahikawa Medical University, Asahikawa, Hokkaido, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Sleep CLIP: A Multimodal Sleep Staging Model Based on Sleep Signals and Sleep Staging Labels.",
"datePublished": "2023-08-23",
"url": "https://questionsmedicales.fr/article/37687797",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s23177341"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sleep and obstructive sleep apnea in women with infertility.",
"datePublished": "2023-01-07",
"url": "https://questionsmedicales.fr/article/36609819",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11325-022-02770-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "To sleep or not to sleep: An Italian Control-IQ-uestion.",
"datePublished": "2022-12-12",
"url": "https://questionsmedicales.fr/article/36578959",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2022.996453"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sleep and Sleep Complaints in Juvenile Fibromyalgia Syndrome.",
"datePublished": "2023-01-15",
"url": "https://questionsmedicales.fr/article/36642430",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3899/jrheum.220720"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sleep fragmentation during rapid eye movement sleep and hypertension in obstructive sleep apnea.",
"datePublished": "2022-11-25",
"url": "https://questionsmedicales.fr/article/36583357",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/HJH.0000000000003332"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Effets physiologiques des médicaments",
"item": "https://questionsmedicales.fr/mesh/D045505"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agents neuromédiateurs",
"item": "https://questionsmedicales.fr/mesh/D018377"
},
{
"@type": "ListItem",
"position": 6,
"name": "Agents cholinergiques",
"item": "https://questionsmedicales.fr/mesh/D018678"
},
{
"@type": "ListItem",
"position": 7,
"name": "Inhibiteurs de la libération d'acétylcholine",
"item": "https://questionsmedicales.fr/mesh/D065087"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Inhibiteurs de la libération d'acétylcholine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Inhibiteurs de la libération d'acétylcholine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Inhibiteurs de la libération d'acétylcholine",
"description": "Comment diagnostiquer une inhibition de l'acétylcholine ?\nQuels tests sont utilisés pour évaluer l'acétylcholine ?\nQuels symptômes indiquent une inhibition d'acétylcholine ?\nLes antécédents médicaux sont-ils importants ?\nPeut-on utiliser l'imagerie pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Sleep#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Inhibiteurs de la libération d'acétylcholine",
"description": "Quels sont les symptômes courants d'une inhibition ?\nL'inhibition affecte-t-elle la cognition ?\nY a-t-il des symptômes respiratoires associés ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on avoir des symptômes digestifs ?",
"url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Sleep#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Inhibiteurs de la libération d'acétylcholine",
"description": "Peut-on prévenir l'inhibition d'acétylcholine ?\nL'alimentation joue-t-elle un rôle ?\nL'exercice physique est-il bénéfique ?\nLe stress peut-il aggraver l'inhibition ?\nDes contrôles réguliers sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Sleep#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Inhibiteurs de la libération d'acétylcholine",
"description": "Quels traitements sont disponibles pour l'inhibition ?\nLes traitements sont-ils efficaces ?\nY a-t-il des effets secondaires aux traitements ?\nLa rééducation est-elle recommandée ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Sleep#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Inhibiteurs de la libération d'acétylcholine",
"description": "Quelles complications peuvent survenir ?\nL'inhibition peut-elle entraîner des hospitalisations ?\nY a-t-il un risque de décès ?\nLes complications sont-elles réversibles ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Sleep#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Inhibiteurs de la libération d'acétylcholine",
"description": "Quels sont les facteurs de risque d'inhibition ?\nL'âge est-il un facteur de risque ?\nLes médicaments peuvent-ils influencer le risque ?\nLe mode de vie affecte-t-il le risque ?\nLes infections virales sont-elles un risque ?",
"url": "https://questionsmedicales.fr/mesh/D065087?mesh_terms=Sleep#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une inhibition de l'acétylcholine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests neurologiques et l'évaluation des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'acétylcholine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests électromyographiques et des analyses sanguines peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une inhibition d'acétylcholine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la faiblesse musculaire et la fatigue peuvent indiquer une inhibition."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux sont-ils importants ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents médicaux aident à identifier des causes potentielles d'inhibition."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'imagerie pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie cérébrale peut aider à exclure d'autres pathologies neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une inhibition ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent faiblesse musculaire, fatigue, et troubles de la coordination."
}
},
{
"@type": "Question",
"name": "L'inhibition affecte-t-elle la cognition ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des troubles de la mémoire et de la concentration."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes respiratoires associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des difficultés respiratoires peuvent survenir en cas d'inhibition sévère."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes digestifs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des nausées et des troubles gastro-intestinaux peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'inhibition d'acétylcholine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mesures préventives incluent un mode de vie sain et la gestion du stress."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée riche en antioxydants peut soutenir la santé neuronale."
}
},
{
"@type": "Question",
"name": "L'exercice physique est-il bénéfique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la fonction musculaire et nerveuse."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver l'inhibition ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut exacerber les symptômes d'inhibition d'acétylcholine."
}
},
{
"@type": "Question",
"name": "Des contrôles réguliers sont-ils nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des contrôles réguliers permettent de surveiller l'évolution et d'ajuster les traitements."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'inhibition ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments anticholinestérasiques et des thérapies physiques."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent améliorer les symptômes et la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des nausées et des crampes peuvent survenir."
}
},
{
"@type": "Question",
"name": "La rééducation est-elle recommandée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la rééducation physique peut aider à renforcer les muscles et améliorer la fonction."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction des besoins individuels du patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles respiratoires et des crises musculaires."
}
},
{
"@type": "Question",
"name": "L'inhibition peut-elle entraîner des hospitalisations ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des cas graves peuvent nécessiter une hospitalisation pour surveillance."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de décès ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans des cas extrêmes, l'inhibition sévère peut entraîner des risques mortels."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite une approche multidisciplinaire et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'inhibition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des maladies auto-immunes, des infections et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé est un facteur de risque pour les troubles de la libération d'acétylcholine."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils influencer le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent augmenter le risque d'inhibition d'acétylcholine."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les infections virales sont-elles un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales peuvent déclencher des troubles de la libération d'acétylcholine."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 01/05/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
Division of Genomic Science and Microbiology, School of Medicine, University of Fukui, Eiheiji, Fukui, Japan.
Kimura Hospital, Awara, Fukui, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
Division of Cellular Signal Transduction, Department of Biochemistry, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
3 publications dans cette catégorie
Affiliations :
Division of Genomic Science and Microbiology, School of Medicine, University of Fukui, Eiheiji, Fukui, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Division of Cellular Signal Transduction, Department of Biochemistry, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Division of Cellular Signal Transduction, Department of Biochemistry, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Pharmacology, School of Medicine, Tokai University, Isehara 259-1193, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Tokyo Dental College, Misaki-cho, Chiyoda-ku, Tokyo 101-0061, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Neuroimmune Signaling, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia (D.S.L., E.V.K., I.A.I., N.S.E., N.D.T., E.N.S., E.Y.T., A.E.S., D.S.K., I.E.K., V.I.T.); Department of Neurobiology, Hellenic Pasteur Institute, Athens, Greece (M.Z., S.J.T.); Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russia (I.E.K.); Institute of Chemistry and Molecular Engineering, Agricultural University of Georgia, Kakha Bendukidze University Campus, Tbilisi, Georgia (R.K., N.Z., I.I.); and PhysBio of MePhI, Moscow, Russia (V.I.T.) victortsetlin3f@gmail.com.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan. Electronic address: torukawa@ncvc.go.jp.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiac Physiology, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiac Physiology, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiac Physiology, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Kazan Institute of Biochemistry and Biophysics FRC Kazan Scientific Center of RAS, PB 30, Kazan 420111, Russia. Electronic address: ellyab@mail.ru.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
a Department of Pharmacy , Peking University People's Hospital , Beijing 100730 , China.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
2 publications dans cette catégorie
Affiliations :
b Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation, Department of Clinical Pharmacology , Beijing Hospital , Bejing 100044 , China.
Publications dans "Inhibiteurs de la libération d'acétylcholine" :
Since the release of the contrastive language-image pre-training (CLIP) model designed by the OpenAI team, it has been applied in several fields owing to its high accuracy. Sleep staging is an importa...
Obstructive sleep apnea (OSA) is associated with polycystic ovarian syndrome (PCOS), a common cause of infertility. Understanding predictors and outcomes of OSA in women with infertility may guide tre...
A descriptive cross-sectional survey was performed to assess OSA in women presenting to an infertility clinic using validated sleep questionnaires to assess sleep and fertility outcomes. An Infertile-...
In 258 women, occurrences of OSA diagnosis (6%) and RLS (10%) were reported similar to women of child-bearing age in the general population. PCOS was unassociated with OSA risk. Predictors of OSA risk...
Similar to other populations, women with infertility and OSA risk have more health comorbidities and higher BMI and may present with insomnia symptoms. While the data are limited, this study supports ...
Tandem Control-IQ is an advanced hybrid closed loop (AHCL) system with a Sleep Activity Mode to intensify glycemic control overnight. The aim of the study is to evaluate the effectiveness of using Sle...
We performed a retrospective Tandem Control-IQ data download for patients followed at IRCCS G. Gaslini Pediatric Diabetes Centre. We divided the patients into group 1 (Sleep Mode users) and group 2 (n...
Group 1 (...
This is the first study that evaluates the real-life effectiveness of the use of Sleep Mode in young patients with T1D. Control-IQ Sleep Activity Mode may not be as effective in Italian patients as in...
To investigate sleep quality in juvenile fibromyalgia syndrome (JFS) and its effect on the global burden of the disease....
Consecutive patients with JFS who performed full-night polysomnography (PSG) were included in this cross-sectional study. JFS-related symptoms, neuropsychiatric features, and sleep quality were assess...
We included 25 patients (20 females, median age 15.7 yrs). Nonrestorative sleep was reported by 22 of 25 (88%) patients. Patients with JFS showed significantly longer sleep period time (...
Sleep complaints are a key hallmark of JFS and have significant effect on relevant clinical domains of the disease, such as pain and depression....
Sleep fragmentation determined by repetitive arousals from sleep in obstructive sleep apnea (OSA) is associated with hypertension. We aimed to quantify the independent association of arousals during r...
We included adults with 4 h of total sleep time and at least 30 min of REM sleep obtained from overnight in-laboratory polysomnography. Logistic regression models were fitted to explore the associatio...
The sample comprised of 11 643 patients, of which 10 055 were OSA patients. Fully adjusted models demonstrated significant dose-relationships between arousal index during REM sleep (AI-REM) and preval...
Our findings indicate that arousals during REM sleep are associated with prevalent hypertension. This is clinically relevant because treatment of OSA is often limited to the first half of the sleep pe...
Although many people suffer from sleep disorders, most are undiagnosed, leading to impairments in health. The existing polysomnography method is not easily accessible; it's costly, burdensome to patie...
Current evidence points to the importance of sleep for adolescent physical and mental health. To date, most studies have examined the association between sleep duration/quality and health in adolescen...
Almost one billion people worldwide are affected by Obstructive Sleep Apnea (OSA). Affected individuals experience disordered breathing patterns during sleep, which results in fatigue, daytime drowsin...
Patient-generated health data are important in the management of several diseases. Although there are limitations, information can be obtained using a wearable device and time-related information such...
To effectively use patient-generated health data related to time such as sleep, it is first necessary to understand the characteristics of the time response recorded by the user. Therefore, the aim of...
Sleep data were acquired for 2 weeks using a Fitbit. Participants' sleep records were collected daily through chatbot conversations while wearing the Fitbit, and the two sets of data were statisticall...
In total, 736 people aged 30-59 years were recruited for this study, and the sleep data of 543 people who wore a Fitbit and responded to the chatbot for more than 7 days on the same day were analyzed....
The chatbot sleep response and Fitbit measured time were similar on average and the study participants had a slight tendency to perceive a relatively long sleep time if the quality of sleep was self-r...
Depression, poor sleep duration and low self-efficacy are common in mothers of children with sleep problems. However, research rarely extends beyond the postpartum period. This study investigated the ...